Oligonucleotide Synthesis Market was valued at US$ 6.60 Bn in 2023 and is expected to reach 17.43 Bn by 2030, at a CAGR of 14.87% during the forecast period. The report includes an analysis of the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region.To know about the Research Methodology :- Request Free Sample Report
Oligonucleotide Synthesis Market Dynamics:
The oligonucleotide synthesis market has found major development in the recent years and is anticipated to grow tremendously during the forecast period. Oligonucleotides are short sections of nucleic acids that are united utilizing enzyme chemistry and genetic engineering. These are utilized for diagnostics, therapeutic, and in addition industrial and academic. Oligonucleotides synthesis takes place technologically to give services to different end-users or independently by means of DNA synthesizers for self-utilization. The global market for oligonucleotide synthesis may also face a restriction in its growth due to the lack of available resources. The oligonucleotide synthesis market is expected to witness limitations in the availability of funding for research in academic laboratories, which may hamper market revenue growth. Along with this, there are also a restricted number of market players existing in some regions and a shortage of skilled personnel. These factors may hinder the growth of research activities.Oligonucleotide Synthesis Market Segment Analysis:
The synthesized oligos segment held the largest share of the market in 2023 and is expected to grow at the highest CAGR during the forecast period. Growth in this segment is attributed to the growing applications of synthesized oligos in therapeutics, research, and diagnostics. The biotechnology & Pharmaceutical Companies segment is expected to lead the market for oligonucleotide synthesis. Pharmaceutical industries and biotechnology companies are focused on looking for alternative approaches for disease treatment. As a result, these companies are making major use of oligonucleotides, as it offers an effective mode of action for the treatment of several indications at comparatively lower development costs.Oligonucleotide Synthesis Market Regional Insights:
North America is expected to hold the largest market size for the oligonucleotide synthesis globally. The Asian market size is expected to grow at the highest CAGR, mainly owing to the rising accessibility of synthesized oligos, along with a rise in R&D funding and activities in the region. Japan and China are considered the most attractive markets with respect to growth opportunities present in these countries. Additionally, changing economic scenario, along with high investments in healthcare, life science-related research programs, and genetics, has encouraged global players to enter the Asia Pacific market, thus helping its growth. Recent developments in the market for oligonucleotide synthesis: In March 2018, Danaher Corporation publicized that they have acquired Integrated DNA Technologies. The main of the acquisition is to increase their business in the genomics market and with IDT to develop critical diagnostic tests and potential life-saving therapies. They want to provide consumers highest standards of quality, service, and technical expertise. In February 2021, Integrated DNA Technologies announced that they have acquired GeneWorks Pty Ltd. The main goal of the acquisition is to expand its business in the Asia- Pacific regions. They want to provide high-quality products and services to the scientist around the world. The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data, and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Oligonucleotide Synthesis Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence.Oligonucleotide Synthesis Industry Ecosystem
Oligonucleotide Synthesis Market, Key Highlights:
1. Global Oligonucleotide Synthesis Market analysis and forecast, in terms of value. 2. Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Oligonucleotide Synthesis Market 3. Global Oligonucleotide Synthesis Market segmentation on the basis of Product Type, Application, end-user, and region (country-wise) has been provided. 4. Global Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study. 5. Global Oligonucleotide Synthesis Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation. 6. Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled. 7. Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Market are also profiled.Oligonucleotide Synthesis Market Report Scope : Inquire before buying
Oligonucleotide Synthesis Market Report Coverage Details Base Year: 2023 Forecast Period: 2024-2030 Historical Data: 2018 to 2023 Market Size in 2023: US $ 6.60 Bn. Forecast Period 2024 to 2030 CAGR: 14.87% Market Size in 2030: US $ 17.43 Bn. Segments Covered: by Product Type Reagents & Consumables Equipment Synthesized oligonucleotides DNA oligonucleotides RNA oligonucleotides Others by Application Research Polymerase Chain Reaction (PCR) Next Generation Sequencing Therapeutics Antisense Oligonucleotides Nucleic Acid Aptamers Diagnostics Others by End User Hospital Pharmaceutical & Biotechnology Companies Diagnostic Laboratories CROs & CMOs Academic Research Institutes Oligonucleotide Synthesis Market, by Region
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) South America (Brazil, Argentina Rest of South America)Oligonucleotide Synthesis Market, Key Players:
1. Gilent Technologies 2. Adtbio 3. Bioautomation 4. Bio-Synthesis Inc. 5. Eurofins Genomics 6. Eurogentec 7. GE Healthcare 8. Genscript 9. Genedesign 10. Integrated DNA Technologies 11. LGC Biosearch Technologies 12. Merck KGaA 13. Nitto Denko Avecia 14. Thermo Fisher Scientific 15. Trilink Biotechnologies 16. Agilent Technologies, Inc. 17. Adtbio 18. Sarepta Therapeutics, Inc. (US). 19. Danaher Corporation 20. GeneDesign, Inc. 21. Kaneka Corporation (Japan) 22. Maravai Lifesciences Holdings, Inc. (US) 23. Azenta, Inc. (US) 24. Twist Bioscience Corporation (US) Frequently Asked Questions: 1. Which region has the largest share in Global Oligonucleotide Synthesis Market? Ans: North America region held the highest share in 2023. 2. What is the growth rate of Global Oligonucleotide Synthesis Industry? Ans: The Market is expected to grow at a CAGR of 14.87% during forecast period 2024-2030. 3. What is scope of the Global Oligonucleotide Synthesis market report? Ans: The report helps with the PESTEL, PORTER, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Oligonucleotide Synthesis market? Ans: The important key players in the Market are – Gilent Technologies, Adtbio, Bioautomation, Bio-Synthesis Inc., Eurofins Genomics, Eurogentec, GE Healthcare, Genscript, Genedesign, Integrated DNA Technologies, LGC Biosearch Technologies, Merck KGaA, Nitto Denko Avecia, Thermo Fisher Scientific, Trilink Biotechnologies, Agilent Technologies, Inc, Adtbio, Sarepta Therapeutics, Inc. (US), Danaher Corporation, GeneDesign, and Inc. 5. What is the study period of this market? Ans: The Market is studied from 2023 to 2030.
1. Oligonucleotide Synthesis Market Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 1.3. Executive Summary 2. Global Oligonucleotide Synthesis Market: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Market share analysis of major players 2.4. Products specific analysis 2.4.1. Main suppliers and their market positioning 2.4.2. Key customers and adoption rates across different sectors 2.5. Key Players Benchmarking 2.5.1. Company Name 2.5.2. Product Segment 2.5.3. End-user Segment 2.5.4. Revenue (2023) 2.5.5. Key Development 2.5.6. Geographic distribution of major customers 2.6. Market Structure 2.6.1. Market Leaders 2.6.2. Market Followers 2.6.3. Emerging Players 2.7. Mergers and Acquisitions Details 2.8. Pricing Analysis 3. Oligonucleotide Synthesis Market: Dynamics 3.1. Oligonucleotide Synthesis Market Trends 3.2. Oligonucleotide Synthesis Market Dynamics 3.2.1. Drivers 3.2.2. Restraints 3.2.3. Opportunities 3.2.4. Challenges 3.3. PORTER’s Five Forces Analysis 3.3.1. Threat of New Entrants 3.3.2. Threat of Substitutes 3.3.3. Bargaining Power of Suppliers 3.3.4. Bargaining Power of Buyers 3.3.5. Intensity of Competitive Rivalry 3.4. PESTLE Analysis 3.5. Regulatory Landscape by Region 3.5.1. North America 3.5.2. Europe 3.5.3. Asia Pacific 3.5.4. South America 3.5.5. ME&A 3.6. Value Chain Analysis 3.7. Trends/Disruptions Impacting Customer's Business 3.8. Technology Analysis 3.8.1. Key Technologies 3.8.1.1. Solid-phase synthesis 3.8.1.2. Liquid-phase synthesis 3.8.1.3. Enzymatic oligo synthesis 3.8.2. Complementary Technologies 3.8.2.1. Polymerase chain reaction (PCR) 3.8.2.2. Next-generation sequencing 3.8.3. Adjacent Technologies 3.8.3.1. Clustered regularly interspaced short palindromic repeats (CRISPR) 3.8.4. Technological Roadmap 3.9. Ecosystem Analysis 3.9.1. Role in Ecosystem 3.10. Trade Analysis 3.11. Patent Analysis 3.11.1. Number of Patent Holders 3.11.2. Patent Registration Number 3.12. Key Stakeholder and Buying Criteria 3.12.1. Influence of Stakeholders on Buying Process for Oligonucleotide Synthesis Products: Pharmaceutical & Biotechnology Companies 3.12.2. Influence of Stakeholders on Buying Process for Oligonucleotide Synthesis Products: Hospitals 3.13. Regulatory Landscape 3.13.1. Regulatory Analysis 3.13.2. Regulatory Bodies, Government Agencies, and Other Organizations 4. Oligonucleotide Synthesis Market: Global Market Size and Forecast by Segmentation (by Value in USD Mn.) (2023-2030) 4.1. Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 4.1.1. Reagents & Consumables 4.1.2. Equipment 4.1.3. Synthesized oligonucleotides 4.1.4. DNA oligonucleotides 4.1.5. RNA oligonucleotides 4.1.6. Others 4.2. Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 4.2.1. Research 4.2.2. Polymerase Chain Reaction (PCR) 4.2.3. Next Generation Sequencing 4.2.4. Therapeutics 4.2.5. Antisense Oligonucleotides 4.2.6. Nucleic Acid Aptamers 4.2.7. Diagnostics 4.2.8. Others 4.3. Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 4.3.1. Hospital 4.3.2. Pharmaceutical & Biotechnology Companies 4.3.3. Diagnostic Laboratories 4.3.4. CROs & CMOs 4.3.5. Academic Research Institutes 4.4. Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 4.4.1. North America 4.4.2. Europe 4.4.3. Asia Pacific 4.4.4. South America 4.4.5. Middle East and Africa 5. North America Oligonucleotide Synthesis Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 5.1. North America Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 5.1.1. Reagents & Consumables 5.1.2. Equipment 5.1.3. Synthesized oligonucleotides 5.1.4. DNA oligonucleotides 5.1.5. RNA oligonucleotides 5.1.6. Others 5.2. North America Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 5.2.1. Research 5.2.2. Polymerase Chain Reaction (PCR) 5.2.3. Next Generation Sequencing 5.2.4. Therapeutics 5.2.5. Antisense Oligonucleotides 5.2.6. Nucleic Acid Aptamers 5.2.7. Diagnostics 5.2.8. Others 5.3. North America Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 5.3.1. Hospital 5.3.2. Pharmaceutical & Biotechnology Companies 5.3.3. Diagnostic Laboratories 5.3.4. CROs & CMOs 5.3.5. Academic Research Institutes 5.4. North America Oligonucleotide Synthesis Market Size and Forecast, by Country (2023-2030) 5.4.1. United States 5.4.1.1. United States Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 5.4.1.1.1. Reagents & Consumables 5.4.1.1.2. Equipment 5.4.1.1.3. Synthesized oligonucleotides 5.4.1.1.4. DNA oligonucleotides 5.4.1.1.5. RNA oligonucleotides 5.4.1.1.6. Others 5.4.1.2. United States Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 5.4.1.2.1. Research 5.4.1.2.2. Polymerase Chain Reaction (PCR) 5.4.1.2.3. Next Generation Sequencing 5.4.1.2.4. Therapeutics 5.4.1.2.5. Antisense Oligonucleotides 5.4.1.2.6. Nucleic Acid Aptamers 5.4.1.2.7. Diagnostics 5.4.1.2.8. Others 5.4.1.3. United States Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 5.4.1.3.1. Hospital 5.4.1.3.2. Pharmaceutical & Biotechnology Companies 5.4.1.3.3. Diagnostic Laboratories 5.4.1.3.4. CROs & CMOs 5.4.1.3.5. Academic Research Institutes 5.4.2. Canada 5.4.2.1. Canada Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 5.4.2.1.1. Reagents & Consumables 5.4.2.1.2. Equipment 5.4.2.1.3. Synthesized oligonucleotides 5.4.2.1.4. DNA oligonucleotides 5.4.2.1.5. RNA oligonucleotides 5.4.2.1.6. Others 5.4.2.2. Canada Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 5.4.2.2.1. Research 5.4.2.2.2. Polymerase Chain Reaction (PCR) 5.4.2.2.3. Next Generation Sequencing 5.4.2.2.4. Therapeutics 5.4.2.2.5. Antisense Oligonucleotides 5.4.2.2.6. Nucleic Acid Aptamers 5.4.2.2.7. Diagnostics 5.4.2.2.8. Others 5.4.2.3. Canada Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 5.4.2.3.1. Hospital 5.4.2.3.2. Pharmaceutical & Biotechnology Companies 5.4.2.3.3. Diagnostic Laboratories 5.4.2.3.4. CROs & CMOs 5.4.2.3.5. Academic Research Institutes 5.4.3. Mexico 5.4.3.1. Mexico Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 5.4.3.1.1. Reagents & Consumables 5.4.3.1.2. Equipment 5.4.3.1.3. Synthesized oligonucleotides 5.4.3.1.4. DNA oligonucleotides 5.4.3.1.5. RNA oligonucleotides 5.4.3.1.6. Others 5.4.3.2. Mexico Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 5.4.3.2.1. Research 5.4.3.2.2. Polymerase Chain Reaction (PCR) 5.4.3.2.3. Next Generation Sequencing 5.4.3.2.4. Therapeutics 5.4.3.2.5. Antisense Oligonucleotides 5.4.3.2.6. Nucleic Acid Aptamers 5.4.3.2.7. Diagnostics 5.4.3.2.8. Others 5.4.3.3. Mexico Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 5.4.3.3.1. Hospital 5.4.3.3.2. Pharmaceutical & Biotechnology Companies 5.4.3.3.3. Diagnostic Laboratories 5.4.3.3.4. CROs & CMOs 5.4.3.3.5. Academic Research Institutes 6. Europe Oligonucleotide Synthesis Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 6.1. Europe Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 6.2. Europe Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 6.3. Europe Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 6.4. Europe Oligonucleotide Synthesis Market Size and Forecast, by Country (2023-2030) 6.4.1. United Kingdom 6.4.1.1. United Kingdom Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 6.4.1.2. 6.4.1.1. United Kingdom Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 6.4.1.3. United Kingdom Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 6.4.2. France 6.4.2.1. France Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 6.4.2.2. France Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 6.4.2.3. France Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 6.4.3. Germany 6.4.3.1. Germany Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 6.4.3.2. Germany Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 6.4.3.3. Germany Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 6.4.4. Italy 6.4.4.1. Italy Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 6.4.4.2. Italy Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 6.4.4.3. Italy Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 6.4.5. Spain 6.4.5.1. Spain Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 6.4.5.2. Spain Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 6.4.5.3. Spain Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 6.4.6. Sweden 6.4.6.1. Sweden Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 6.4.6.2. Sweden Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 6.4.6.3. Sweden Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 6.4.7. Austria 6.4.7.1. Austria Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 6.4.7.2. Austria Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 6.4.7.3. Austria Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 6.4.8. Rest of Europe 6.4.8.1. Rest of Europe Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 6.4.8.2. Rest of Europe Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 6.4.8.3. Rest of Europe Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 7. Asia Pacific Oligonucleotide Synthesis Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 7.1. Asia Pacific Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 7.2. Asia Pacific Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 7.3. Asia Pacific Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 7.4. Asia Pacific Oligonucleotide Synthesis Market Size and Forecast, by Country (2023-2030) 7.4.1. China 7.4.1.1. China Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 7.4.1.2. China Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 7.4.1.3. China Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 7.4.2. S Korea 7.4.2.1. S Korea Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 7.4.2.2. S Korea Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 7.4.2.3. S Korea Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 7.4.3. Japan 7.4.3.1. Japan Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 7.4.3.2. Japan Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 7.4.3.3. Japan Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 7.4.4. India 7.4.4.1. India Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 7.4.4.2. India Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 7.4.4.3. India Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 7.4.5. Australia 7.4.5.1. Australia Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 7.4.5.2. Australia Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 7.4.5.3. Australia Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 7.4.6. ASIAN 7.4.6.1. ASIAN Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 7.4.6.2. ASIAN Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 7.4.6.3. ASIAN Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 7.4.7. Rest of Asia Pacific 7.4.7.1. Rest of Asia Pacific Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 7.4.7.2. Rest of Asia Pacific Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 7.4.7.3. Rest of Asia Pacific Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 8. South America Oligonucleotide Synthesis Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 8.1. South America Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 8.2. South America Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 8.3. South America Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 8.4. South America Oligonucleotide Synthesis Market Size and Forecast, by Country (2023-2030) 8.4.1. Brazil 8.4.1.1. Brazil Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 8.4.1.2. Brazil Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 8.4.1.3. Brazil Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 8.4.2. Argentina 8.4.2.1. Argentina Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 8.4.2.2. Argentina Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 8.4.2.3. Argentina Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 8.4.3. Rest Of South America 8.4.3.1. Rest of South America Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 8.4.3.2. Rest of South America Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 8.4.3.3. Rest of South America Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 9. Middle East and Africa Oligonucleotide Synthesis Market Size and Forecast by Segmentation (by Value in USD Million) (2023-2030) 9.1. Middle East and Africa Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 9.2. Middle East and Africa Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 9.3. Middle East and Africa Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 9.4. Middle East and Africa Oligonucleotide Synthesis Market Size and Forecast, by Country (2023-2030) 9.4.1. South Africa 9.4.1.1. South Africa Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 9.4.1.2. South Africa Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 9.4.1.3. South Africa Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 9.4.2. GCC 9.4.2.1. GCC Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 9.4.2.2. GCC Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 9.4.2.3. GCC Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 9.4.3. Egypt 9.4.3.1. Egypt Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 9.4.3.2. Egypt Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 9.4.3.3. Egypt Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 9.4.4. Nigeria 9.4.4.1. Nigeria Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 9.4.4.2. Nigeria Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 9.4.4.3. Nigeria Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 9.4.5. Rest of ME&A 9.4.5.1. Rest of ME&A Oligonucleotide Synthesis Market Size and Forecast, by Product Type (2023-2030) 9.4.5.2. Rest of ME&A Oligonucleotide Synthesis Market Size and Forecast, by Application (2023-2030) 9.4.5.3. Rest of ME&A Oligonucleotide Synthesis Market Size and Forecast, by End User (2023-2030) 10. Company Profile: Key Players 10.1. Adtbio 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.3.1. Total Revenue 10.1.3.2. Segment Revenue 10.1.3.3. Annual Revenue 10.1.4. SWOT Analysis 10.1.5. Strategic Analysis 10.1.6. Recent Developments 10.2. Bioautomation 10.3. Bio-Synthesis Inc. 10.4. Eurofins Genomics 10.5. Eurogentec 10.6. GE Healthcare 10.7. Genscript 10.8. GeneDesign, Inc. 10.9. Integrated DNA Technologies 10.10. LGC Biosearch Technologies 10.11. Merck KGaA 10.12. Nitto Denko Avecia 10.13. Thermo Fisher Scientific 10.14. Trilink Biotechnologies 10.15. Sarepta Therapeutics, Inc. (US). 10.16. Danaher Corporation 10.17. Kaneka Corporation (Japan) 10.18. Maravai Lifesciences Holdings, Inc. (US) 10.19. Azenta, Inc. (US) 10.20. Twist Bioscience Corporation (US) 11. Key Findings and Analyst Recommendations 11.1. Attractive Opportunities for Players in Oligonucleotide Synthesis Market 12. Oligonucleotide Synthesis Market: Research Methodology
